Effect of Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
This randomized trial compares the effect of recombinant human soluble thrombomodulin vs placebo in patients with sepsis-associated coagulopathy on 28-day all-cause mortality.
